JENIA HEAVENS: Open Payments
NPI 1508255662 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 35 payments from 12 companies in 2025. Trend: 2023 $254 · 2024 $399 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $144 |
| Indivior Inc. | 6 | $118 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
| Alkermes, Inc. | 3 | $64 |
| Braeburn Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| ABBVIE INC. | 3 | $52 |
| Tris Pharma Inc | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: CAPLYTA, SUBLOCADE, FANAPT, BRIXADI, ABILIFY ASIMTUFII, VRAYLAR, VIVITROL, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
